Evidence map›Paper›PMID 37004054›Full record

ArticleBMC medical ethics2023

Severity as a moral qualifier of malady.

Carl Tollef Solberg, Mathias Barra, Lars Sandman, Bjørn Hoffmann

Abstract read
In one paragraph

Article in BMC medical ethics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Carl Tollef SolbergCentre for Medical Ethics (CME), Institute of Health and Society, Faculty of Medicine, University of Oslo, Kirkeveien 166, Postbox 1130, 0318, Oslo, Norway. c.t.solberg@medisin.uio.no.ORCID 0000-0003-3321-3793
Mathias BarraThe Health Services Research Unit-HØKH, Akershus University Hospital HF, Lørenskog, Norway.ORCID 0000-0002-0022-4042
Lars SandmanDepartment of Health, Medicine and Caring Sciences, The National Centre for Priorities in Health, Linköping University, Linköping, Sweden.ORCID 0000-0003-0987-7653
Bjørn HoffmannCentre for Medical Ethics (CME), Institute of Health and Society, Faculty of Medicine, University of Oslo, Kirkeveien 166, Postbox 1130, 0318, Oslo, Norway.ORCID 0000-0001-6709-4265

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The overarching aim of this article is to scrutinize how severity can work as a qualifier for the moral impetus of malady. While there is agreement that malady is of negative value, there is disagreement about precisely how this is so. Nevertheless, alleviating disease, injury, and associated suffering is almost universally considered good. Furthermore, the strength of a diseased person's moral claims for our attention and efforts will inevitably vary. This article starts by reflecting on what kind of moral impetus malady incites. We then analyze how severity may qualify this impetus. We do so by discussing the relationship between severity and need, well-being and disvalue, death, urgency, rule of rescue, and distributive justice. We then summarize our thoughts about severity as a moral qualifier. We conclude that severity is, and should continue to be seen, as a morally significant concept that deserves continued attention in the future.

Indexed as

MoralsSocial JusticeDissent and DisputesHumansDecision makingMedical humanitiesPhilosophyRationing/resource allocation

Identifiers

PMID37004054
PMCPMC10064741

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.